Business Acquisitions and Divestitures (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Dec. 31, 2023 |
|
| Business Acquisition [Line Items] | |||||
| Goodwill | $ 25,962 | $ 25,962 | $ 25,317 | ||
| Gain on sale of business | 240 | $ 0 | 240 | $ 0 | |
| Paragon Healthcare, Inc. | |||||
| Business Acquisition [Line Items] | |||||
| Finite-lived intangible assets acquired | 411 | 411 | |||
| Goodwill | 753 | 753 | |||
| Measurement period adjustments | (25) | ||||
| BioPlus Parent, LLC and Subsidiaries | |||||
| Business Acquisition [Line Items] | |||||
| Finite-lived intangible assets acquired | 820 | 820 | |||
| Goodwill | 893 | $ 893 | |||
| Carelon Management Services Inc | |||||
| Business Acquisition [Line Items] | |||||
| Goodwill, impairment loss | $ 44 | ||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|